{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET study", "MD simulation", "SARS-CoV-2 3CLpro", "docking computations", "marine natural products (MNPs)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36680290", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "15"}], "Language": ["eng"], "ELocationID": ["250", "10.3390/v15010250"], "Journal": {"ISSN": "1999-4915", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan", "Day": "15"}}, "Title": "Viruses", "ISOAbbreviation": "Viruses"}, "ArticleTitle": "Chetomin, a SARS-CoV-2 3C-like Protease (3CL<sup>pro</sup>) Inhibitor: <i>In Silico</i> Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis.", "Abstract": {"AbstractText": ["The emergence of the Coronavirus Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over 6 million deaths. The 3C-like protease (3CLpro) enzyme of the SARS-CoV-2 virus is an attractive druggable target for exploring therapeutic drug candidates to combat COVID-19 due to its key function in viral replication. Marine natural products (MNPs) have attracted considerable attention as alternative sources of antiviral drug candidates. In looking for potential 3CLpro inhibitors, the MNP database (>14,000 molecules) was virtually screened against 3CLpro with the assistance of molecular docking computations. The performance of AutoDock and OEDocking software in anticipating the ligand-3CLpro binding mode was first validated according to the available experimental data. Based on the docking scores, the most potent MNPs were further subjected to molecular dynamics (MD) simulations, and the binding affinities of those molecules were computed using the MM-GBSA approach. According to MM-GBSA//200 ns MD simulations, chetomin (UMHMNP1403367) exhibited a higher binding affinity against 3CLpro than XF7, with \u0394Gbinding values of \u221255.5 and \u221243.7 kcal/mol, respectively. The steadiness and tightness of chetomin with 3CLpro were evaluated, revealing the high stabilization of chetomin (UMHMNP1403367) inside the binding pocket of 3CLpro throughout 200 ns MD simulations. The physicochemical and pharmacokinetic features of chetomin were also predicted, and the oral bioavailability of chetomin was demonstrated. Furthermore, the potentiality of chetomin analogues \u2212namely, chetomin A-D\u2212 as 3CLpro inhibitors was investigated. These results warrant further in vivo and in vitro assays of chetomin (UMHMNP1403367) as a promising anti-COVID-19 drug candidate."]}, "AuthorList": [{"Identifier": ["0000-0003-4819-2040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}, {"Identifier": [], "Affiliation": "School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": ["0000-0003-3527-0126"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Mohamed", "ForeName": "Dina E M", "Initials": "DEM"}, {"Identifier": ["0000-0001-8667-664X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Abdeljawaad", "ForeName": "Khlood A A", "Initials": "KAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ain Shams University Specialized Hospital, Ain Shams University, Cairo 11588, Egypt."}], "LastName": "Naeem", "ForeName": "Mohamed Ahmed", "Initials": "MA"}, {"Identifier": ["0000-0002-5028-9952"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center, Giza 12619, Egypt."}], "LastName": "Gabr", "ForeName": "Gamal A", "Initials": "GA"}, {"Identifier": ["0000-0002-3035-661X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Science and Technology Unit (STU), Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Shawky", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa."}], "LastName": "Soliman", "ForeName": "Mahmoud E S", "Initials": "MES"}, {"Identifier": ["0000-0003-2579-6351"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "Sidhom", "ForeName": "Peter A", "Initials": "PA"}, {"Identifier": ["0000-0003-1644-723X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA."}], "LastName": "Par\u00e9", "ForeName": "Paul W", "Initials": "PW"}, {"Identifier": ["0000-0002-0343-4969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Viruses", "NlmUniqueID": "101509722", "ISSNLinking": "1999-4915"}, "ChemicalList": [{"RegistryNumber": "1403-36-7", "NameOfSubstance": "chetomin"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Cysteine Endopeptidases"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Viral Nonstructural Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cysteine Endopeptidases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536\u2013544. doi: 10.1038/s41564-020-0695-z.", "ArticleIdList": ["10.1038/s41564-020-0695-z", "PMC7095448", "32123347"]}, {"Citation": "Sohrabi C., Alsafi Z., O\u2019Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) Int. J. Surg. 2020;76:71\u201376. doi: 10.1016/j.ijsu.2020.02.034.", "ArticleIdList": ["10.1016/j.ijsu.2020.02.034", "PMC7105032", "32112977"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "She J., Jiang J., Ye L., Hu L., Bai C., Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: Emerging attack and management strategies. Clin. Transl. Med. 2020;9:19. doi: 10.1186/s40169-020-00271-z.", "ArticleIdList": ["10.1186/s40169-020-00271-z", "PMC7033263", "32078069"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Mishra N.P., Das S.S., Yadav S., Khan W., Afzal M., Alarifi A., Kenawy E.R., Ansari M.T., Hasnain M.S., Nayak A.K. Global impacts of pre- and post-COVID-19 pandemic: Focus on socio-economic consequences. Sens. Int. 2020;1:100042. doi: 10.1016/j.sintl.2020.100042.", "ArticleIdList": ["10.1016/j.sintl.2020.100042", "PMC7510561", "34766044"]}, {"Citation": "Telenti A., Arvin A., Corey L., Corti D., Diamond M.S., Garcia-Sastre A., Garry R.F., Holmes E.C., Pang P.S., Virgin H.W. After the pandemic: Perspectives on the future trajectory of COVID-19. Nature. 2021;596:495\u2013504. doi: 10.1038/s41586-021-03792-w.", "ArticleIdList": ["10.1038/s41586-021-03792-w", "34237771"]}, {"Citation": "Astuti I., Ysrafil Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. 2020;14:407\u2013412. doi: 10.1016/j.dsx.2020.04.020.", "ArticleIdList": ["10.1016/j.dsx.2020.04.020", "PMC7165108", "32335367"]}, {"Citation": "Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92:418\u2013423. doi: 10.1002/jmv.25681.", "ArticleIdList": ["10.1002/jmv.25681", "PMC7167049", "31967327"]}, {"Citation": "Li Q., Kang C. Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease. Microorganisms. 2020;8:1250. doi: 10.3390/microorganisms8081250.", "ArticleIdList": ["10.3390/microorganisms8081250", "PMC7463875", "32824639"]}, {"Citation": "Suarez D., Diaz N. SARS-CoV-2 Main Protease: A Molecular Dynamics Study. J. Chem. Inf. Model. 2020;60:5815\u20135831. doi: 10.1021/acs.jcim.0c00575.", "ArticleIdList": ["10.1021/acs.jcim.0c00575", "32678588"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hegazy M.F. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 2021;39:5756\u20135767. doi: 10.1080/07391102.2020.1791958.", "ArticleIdList": ["10.1080/07391102.2020.1791958", "PMC7441803", "32684114"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Allemailem K.S., Almatroudi A., Moustafa M.F., Hegazy M.F. In Silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors. Protein J. 2021;40:296\u2013309. doi: 10.1007/s10930-020-09945-6.", "ArticleIdList": ["10.1007/s10930-020-09945-6", "PMC7776322", "33387249"]}, {"Citation": "Pawar A.Y. Combating devastating COVID-19 by drug repurposing. Int. J. Antimicrob. Agents. 2020;56:105984. doi: 10.1016/j.ijantimicag.2020.105984.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105984", "PMC7162749", "32305589"]}, {"Citation": "Drozdzal S., Rosik J., Lechowicz K., Machaj F., Kotfis K., Ghavami S., Los M.J. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist. Updates. 2020;53:100719. doi: 10.1016/j.drup.2020.100719.", "ArticleIdList": ["10.1016/j.drup.2020.100719", "PMC7362818", "32717568"]}, {"Citation": "Musarra-Pizzo M., Pennisi R., Ben-Amor I., Mandalari G., Sciortino M.T. Antiviral Activity Exerted by Natural Products against Human Viruses. Viruses. 2021;13:828. doi: 10.3390/v13050828.", "ArticleIdList": ["10.3390/v13050828", "PMC8147851", "34064347"]}, {"Citation": "Lin L.T., Hsu W.C., Lin C.C. Antiviral natural products and herbal medicines. J. Tradit. Complement. Med. 2014;4:24\u201335. doi: 10.4103/2225-4110.124335.", "ArticleIdList": ["10.4103/2225-4110.124335", "PMC4032839", "24872930"]}, {"Citation": "Lichtiger S., Present D.H., Kornbluth A., Gelernt I., Bauer J., Galler G., Michelassi F., Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N. Engl. J. Med. 1994;330:1841\u20131845. doi: 10.1056/NEJM199406303302601.", "ArticleIdList": ["10.1056/NEJM199406303302601", "8196726"]}, {"Citation": "Magnusson I., Ekman L., Wangdahl M., Wahren J. N-Acetyl-L-Tyrosine and N-Acetyl-L-Cysteine as Tyrosine and Cysteine Precursors during Intravenous-Infusion in Humans. Metab. Clin. Exp. 1989;38:957\u2013961. doi: 10.1016/0026-0495(89)90005-X.", "ArticleIdList": ["10.1016/0026-0495(89)90005-X", "2507878"]}, {"Citation": "Mia M.M., Hasan M., Miah M.M., Hossain M.A.S., Islam S., Shanta V. Inhibitory Potentiality of Secondary Metabolites Extracted from Marine Fungus Target on Avian Influenza Virus-A Subtype H5N8 (Neuraminidase) and H5N1 (Nucleoprotein): A Rational Virtual Screening. Vet. Anim. Sci. 2022;15:100231. doi: 10.1016/j.vas.2022.100231.", "ArticleIdList": ["10.1016/j.vas.2022.100231", "PMC8760399", "35059528"]}, {"Citation": "Banerjee P., Mandhare A., Bagalkote V. Marine natural products as source of new drugs: An updated patent review (July 2018\u2013July 2021) Expert Opin. Ther. Pat. 2022;32:317\u2013363. doi: 10.1080/13543776.2022.2012150.", "ArticleIdList": ["10.1080/13543776.2022.2012150", "34872430"]}, {"Citation": "Choudhary A., Naughton L.M., Montanchez I., Dobson A.D.W., Rai D.K. Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials. Mar. Drugs. 2017;15:272. doi: 10.3390/md15090272.", "ArticleIdList": ["10.3390/md15090272", "PMC5618411", "28846659"]}, {"Citation": "Riccio G., Ruocco N., Mutalipassi M., Costantini M., Zupo V., Coppola D., de Pascale D., Lauritano C. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms. Biomolecules. 2020;10:1007. doi: 10.3390/biom10071007.", "ArticleIdList": ["10.3390/biom10071007", "PMC7407529", "32645994"]}, {"Citation": "Yasuhara-Bell J., Lu Y. Marine compounds and their antiviral activities. Antivir. Res. 2010;86:231\u2013240. doi: 10.1016/j.antiviral.2010.03.009.", "ArticleIdList": ["10.1016/j.antiviral.2010.03.009", "PMC7132374", "20338196"]}, {"Citation": "Gogineni V., Schinazi R.F., Hamann M.T. Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem. Rev. 2015;115:9655\u20139706. doi: 10.1021/cr4006318.", "ArticleIdList": ["10.1021/cr4006318", "PMC4883660", "26317854"]}, {"Citation": "Park J.Y., Kim J.H., Kwon J.M., Kwon H.J., Jeong H.J., Kim Y.M., Kim D., Lee W.S., Ryu Y.B. Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorganic Med. Chem. 2013;21:3730\u20133737. doi: 10.1016/j.bmc.2013.04.026.", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Lira S.P.d., Seleghim M.H.R., Williams D.E., Marion F., Hamill P., Jean F., Andersen R.J., Hajdu E., Berlinck R.G.S. A SARS-coronovirus 3CL protease inhibitor isolated from the marine sponge Axinella cf. corrugata: Structure elucidation and synthesis. J. Braz. Chem. Soc. 2007;18:440\u2013443. doi: 10.1590/S0103-50532007000200030.", "ArticleIdList": ["10.1590/S0103-50532007000200030"]}, {"Citation": "Zhang C.H., Stone E.A., Deshmukh M., Ippolito J.A., Ghahremanpour M.M., Tirado-Rives J., Spasov K.A., Zhang S., Takeo Y., Kudalkar S.N., et al. Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations. ACS Cent. Sci. 2021;7:467\u2013475. doi: 10.1021/acscentsci.1c00039.", "ArticleIdList": ["10.1021/acscentsci.1c00039", "PMC7931627", "33786375"]}, {"Citation": "Gordon J.C., Myers J.B., Folta T., Shoja V., Heath L.S., Onufriev A. H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368\u2013W371. doi: 10.1093/nar/gki464.", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "OMEGA. OpenEye Scientific Software; Santa Fe, NM, USA: 2013. Version 2.5.1.4."}, {"Citation": "Hawkins P.C., Skillman A.G., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model. 2010;50:572\u2013584. doi: 10.1021/ci100031x.", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "QUACPAC. OpenEye Scientific Software; Santa Fe, NM, USA: 2016. Version 1.7.0.2."}, {"Citation": "Gasteiger J., Marsili M. Iterative Partial Equalization of Orbital Electronegativity\u2014A Rapid Access to Atomic Charges. Tetrahedron. 1980;36:3219\u20133228. doi: 10.1016/0040-4020(80)80168-2.", "ArticleIdList": ["10.1016/0040-4020(80)80168-2"]}, {"Citation": "Heller S.R., McNaught A., Pletnev I., Stein S., Tchekhovskoi D. InChI, the IUPAC International Chemical Identifier. J. Cheminformatics. 2015;7:23. doi: 10.1186/s13321-015-0068-4.", "ArticleIdList": ["10.1186/s13321-015-0068-4", "PMC4486400", "26136848"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "McGann M. FRED pose prediction and virtual screening accuracy. J. Chem. Inf. Model. 2011;51:578\u2013596. doi: 10.1021/ci100436p.", "ArticleIdList": ["10.1021/ci100436p", "21323318"]}, {"Citation": "McGann M. FRED and HYBRID docking performance on standardized datasets. J. Comput. Aided Mol. Des. 2012;26:897\u2013906. doi: 10.1007/s10822-012-9584-8.", "ArticleIdList": ["10.1007/s10822-012-9584-8", "22669221"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905\u2013919. doi: 10.1038/nprot.2016.051.", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998;19:1639\u20131662. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.", "ArticleIdList": ["10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"]}, {"Citation": "Case D.A., Betz R.M., Cerutti D.S., Cheatham T.E., Darden T.A., Duke R.E., Giese T.J., Gohlke H., Goetz A.W., Homeyer N., et al. AMBER 2016. University of California; San Francisco, CA, USA: 2016."}, {"Citation": "Ibrahim M.A.A., Abdeljawaad K.A.A., Abdelrahman A.H.M., Alzahrani O.R., Alshabrmi F.M., Khalaf E., Moustafa M.F., Alrumaihi F., Allemailem K.S., Soliman M.E.S., et al. Non-beta-lactam allosteric inhibitors target methicillin-resistant staphylococcus aureus: An in Silico drug discovery study. Antibiotics. 2021;10:934. doi: 10.3390/antibiotics10080934.", "ArticleIdList": ["10.3390/antibiotics10080934", "PMC8388891", "34438984"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Badr E.A.A., Almansour N.M., Alzahrani O.R., Ahmed M.N., Soliman M.E.S., Naeem M.A., Shawky A.M., Sidhom P.A., et al. Naturally occurring plant-based anticancerous candidates as prospective ABCG2 inhibitors: An in silico drug discovery study. Mol. Divers. 2022;26:3255\u20133277. doi: 10.1007/s11030-022-10389-6.", "ArticleIdList": ["10.1007/s11030-022-10389-6", "PMC9636125", "35224675"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hassan A.M.A. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations. Comput. Biol. Chem. 2019;80:79\u201389. doi: 10.1016/j.compbiolchem.2019.03.010.", "ArticleIdList": ["10.1016/j.compbiolchem.2019.03.010", "30928871"]}, {"Citation": "Ibrahim M.A.A., Badr E.A.A., Abdelrahman A.H.M., Almansour N.M., Mekhemer G.A.H., Shawky A.M., Moustafa M.F., Atia M.A.M. In Silico targeting human multidrug transporter ABCG2 in breast cancer: Database screening, molecular docking, and molecular dynamics study. Mol. Inform. 2022;41:e2060039. doi: 10.1002/minf.202060039.", "ArticleIdList": ["10.1002/minf.202060039", "34491628"]}, {"Citation": "Ibrahim M.A.A., Badr E.A.A., Abdelrahman A.H.M., Almansour N.M., Shawky A.M., Mekhemer G.A.H., Alrumaihi F., Moustafa M.F., Atia M.A.M. Prospective drug candidates as human multidrug transporter ABCG2 inhibitors: An in Silico drug discovery study. Cell Biochem. Biophys. 2021;79:189\u2013200. doi: 10.1007/s12013-021-00985-y.", "ArticleIdList": ["10.1007/s12013-021-00985-y", "33954893"]}, {"Citation": "Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157\u20131174. doi: 10.1002/jcc.20035.", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696\u20133713. doi: 10.1021/acs.jctc.5b00255.", "ArticleIdList": ["10.1021/acs.jctc.5b00255", "PMC4821407", "26574453"]}, {"Citation": "Jakalian A., Jack D.B., Bayly C.I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 2002;23:1623\u20131641. doi: 10.1002/jcc.10128.", "ArticleIdList": ["10.1002/jcc.10128", "12395429"]}, {"Citation": "Roux B., Simonson T. Implicit solvent models. Biophys. Chem. 1999;78:1\u201320. doi: 10.1016/S0301-4622(98)00226-9.", "ArticleIdList": ["10.1016/S0301-4622(98)00226-9", "17030302"]}, {"Citation": "Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al. Gaussian 09. Gaussian Inc.; Wallingford, CT, USA: 2009. Revision E01."}, {"Citation": "Bayly C.I., Cieplak P., Cornell W.D., Kollman P.A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges-the RESP model. J. Phys. Chem. 1993;97:10269\u201310280. doi: 10.1021/j100142a004.", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089\u201310092. doi: 10.1063/1.464397.", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Miyamoto S., Kollman P.A. Settle-An Analytical Version of the Shake and Rattle Algorithm for Rigid Water Models. J. Comput. Chem. 1992;13:952\u2013962. doi: 10.1002/jcc.540130805.", "ArticleIdList": ["10.1002/jcc.540130805"]}, {"Citation": "Dassault Syst\u00e8mes BIOVIA . Discovery Studio Visualize, Version 2019. Dassault Syst\u00e8mes BIOVIA; San Diego, CA, USA: 2019."}, {"Citation": "Massova I., Kollman P.A. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. 2000;18:113\u2013135. doi: 10.1023/A:1008763014207.", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Weiser J., Shenkin P.S., Still W.C. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) J. Comput. Chem. 1999;20:217\u2013230. doi: 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A.", "ArticleIdList": ["10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J. Comput. Chem. 2011;32:866\u2013877. doi: 10.1002/jcc.21666.", "ArticleIdList": ["10.1002/jcc.21666", "PMC3043139", "20949517"]}, {"Citation": "Wang E., Sun H., Wang J., Wang Z., Liu H., Zhang J.Z.H., Hou T. End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chem. Rev. 2019;119:9478\u20139508. doi: 10.1021/acs.chemrev.9b00055.", "ArticleIdList": ["10.1021/acs.chemrev.9b00055", "31244000"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Geahchan S., Ehrlich H., Rahman M.A. The Anti-Viral Applications of Marine Resources for COVID-19 Treatment: An Overview. Mar. Drugs. 2021;19:409. doi: 10.3390/md19080409.", "ArticleIdList": ["10.3390/md19080409", "PMC8402008", "34436248"]}, {"Citation": "De Vivo M., Masetti M., Bottegoni G., Cavalli A. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 2016;59:4035\u20134061. doi: 10.1021/acs.jmedchem.5b01684.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01684", "26807648"]}, {"Citation": "Kerrigan J.E. Molecular dynamics simulations in drug design. In: Kortagere S., editor. In Silico Models for Drug Discovery. Humana Press; Totowa, NJ, USA: 2013. pp. 95\u2013113.", "ArticleIdList": ["23568466"]}, {"Citation": "Mullard A. Re-assessing the rule of 5, two decades on. Nat. Rev. Drug Discov. 2018;17:777. doi: 10.1038/nrd.2018.197.", "ArticleIdList": ["10.1038/nrd.2018.197", "30374178"]}, {"Citation": "Han Y., Zhang J., Hu C.Q., Zhang X., Ma B., Zhang P. In silico ADME and toxicity prediction of ceftazidime and its impurities. Front. Pharmacol. 2019;10:434\u2013443. doi: 10.3389/fphar.2019.00434.", "ArticleIdList": ["10.3389/fphar.2019.00434", "PMC6491819", "31068821"]}, {"Citation": "Dahlgren D., Lennernas H. Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches. Pharmaceutics. 2019;11:411. doi: 10.3390/pharmaceutics11080411.", "ArticleIdList": ["10.3390/pharmaceutics11080411", "PMC6723276", "31412551"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "16"}, {"Year": "2023", "Month": "1", "Day": "10"}, {"Year": "2023", "Month": "1", "Day": "13"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "1", "Minute": "59"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36680290", "PMC9866112", "10.3390/v15010250", "v15010250"]}}], "PubmedBookArticle": []}